Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Sees Significant Growth in Short Interest

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) saw a large growth in short interest in the month of July. As of July 31st, there was short interest totaling 5,913 shares, a growth of 53.0% from the July 15th total of 3,865 shares. Based on an average trading volume of 3,042 shares, the days-to-cover ratio is currently 1.9 days. Currently, 4.5% of the company’s shares are sold short.

Insider Buying and Selling

In other news, Director Mika K. Derynck sold 158,795 shares of the firm’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $60.21, for a total value of $9,561,046.95. Following the completion of the transaction, the director owned 87,373 shares of the company’s stock, valued at approximately $5,260,728.33. This trade represents a 64.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Helen Louise Collins sold 5,000 shares of Bitwise MARA Option Income Strategy ETF stock in a transaction that occurred on Friday, July 17th. The shares were sold at an average price of $52.67, for a total transaction of $263,350.00. Following the completion of the transaction, the insider owned 25,000 shares of the company’s stock, valued at $1,316,750. This trade represents a 16.67% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,342,362 shares of company stock worth $63,158,240 over the last 90 days. 37.30% of the stock is owned by insiders.

Bitwise MARA Option Income Strategy ETF Price Performance

Shares of IMRA stock opened at $14.59 on Thursday. The firm has a 50 day moving average of $15.64 and a two-hundred day moving average of $15.23. The stock has a market capitalization of $1.90 million, a PE ratio of 291.80 and a beta of 2.74. Bitwise MARA Option Income Strategy ETF has a 52 week low of $11.99 and a 52 week high of $42.32.

Bitwise MARA Option Income Strategy ETF Company Profile

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.